Literature DB >> 7089032

Opiate modification of amygdaloid-kindled seizures in rats.

W S Stone, C E Eggleton, R F Berman.   

Abstract

Male Long-Evans rats were stereotaxically implanted bilaterally with bipolar electrodes in the central amygdala. Rats were then kindled once daily for 1 sec until 3 consecutive Stage V [25] kindled seizures were elicited. On the following day, animals were injected (IP) with either saline, naloxone (10 mg/kg), naltrexone (10mg/kg) or morphine sulfate (10 mg/kg) and again stimulated at the kindling stimulation parameters. Saline injected animals continued to show long bilateral AD's and behaviors (i.e., forelimb clonus, rearing, falling) typical of Stage V kindled animals. In contrast, rats injected with naloxone or naltrexone showed reduced behavioral seizures. Potentiation of post-ictal spiking by morphine in amygdaloid-kindled rats was also observed supporting previous reports [7,21]. In a second experiment, the reduction of kindled seizure serverity by naloxone was systematically replicated. It is concluded that opiates can significantly modify amygdaloid-kindled seizures, and that brain endorphins may play a role in the development or maintenance of an amygdaloid-kindled seizure focus.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7089032     DOI: 10.1016/0091-3057(82)90230-1

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  4 in total

1.  Naloxane enhanced inhibitory effect of verapamil on seizure induced by pentylenetetrazol in male rats.

Authors:  M R Palizvan; E Ghaznavi-Rad
Journal:  Res Pharm Sci       Date:  2014 Jul-Aug

2.  Effects of morphine and D-Ala2-D-Leu5-enkephalin in the seizure-susceptible El mouse.

Authors:  S Koide; H Onishi; S Yamagami; Y Kawakita
Journal:  Neurochem Res       Date:  1992-08       Impact factor: 3.996

3.  Metabolic profile of opioid peptides differs in the hippocampus and striatum of seizure-susceptible E1 mice.

Authors:  S Koide; H Onishi; M Katayama; S Yamagami
Journal:  Neurochem Res       Date:  1995-03       Impact factor: 3.996

4.  The opioid antagonist naltrexone decreases seizure-like activity in genetic and chemically induced epilepsy models.

Authors:  Morgan L Sturgeon; Rachel Langton; Shaunik Sharma; Robert A Cornell; Joseph Glykys; Alexander G Bassuk
Journal:  Epilepsia Open       Date:  2021-06-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.